SEC 13F Intelligence

Bridge City Capital, LLC / LMAT

Bridge City Capital, LLC’s Lemaitre Vascular Inc Position

Does Bridge City Capital, LLC own Lemaitre Vascular Inc (LMAT)? Yes70.4K shares worth $8M (+2.13% of its 13F portfolio) as of Q1 2026, up from 66.6K shares the prior filed quarter.

Position Value
$8M
Q1 2026
Shares
70.4K
% of Portfolio
+2.13%
Quarters Held
29
currently held

Position History LMAT

Reported value by quarter
Q1 ’19: $1MQ1 ’19Q2 ’19: $1MQ3 ’19: $2MQ4 ’19: $2MQ1 ’20: $3MQ1 ’20Q2 ’20: $3MQ3 ’20: $3MQ4 ’20: $4MQ1 ’21: $5MQ1 ’21Q2 ’21: $6MQ3 ’21: $4MQ4 ’21: $4MQ1 ’22: $3MQ1 ’22Q2 ’22: $3MQ3 ’22: $4MQ4 ’22: $3,375Q1 ’23: $4MQ1 ’23Q2 ’23: $4MQ3 ’23: $3MQ4 ’23: $4MQ1 ’24: $5MQ1 ’24Q2 ’24: $7MQ3 ’24: $8MQ4 ’24: $9MQ1 ’25: $6MQ1 ’25Q2 ’25: $6MQ3 ’25: $6MQ4 ’25: $5MQ1 ’26: $8MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202670.4K$8M+2.13%
Q4 202566.6K$5M+1.59%
Q3 202573.9K$6M+1.73%
Q2 202573.5K$6M+1.71%
Q1 202574.4K$6M+1.87%
Q4 202494.5K$9M+2.32%
Q3 202488.0K$8M+2.25%
Q2 202490.2K$7M+2.49%
Q1 202473.2K$5M+1.77%
Q4 202371.3K$4M+1.57%
Q3 202358.9K$3M+1.62%
Q2 202357.1K$4M+1.82%
Q1 202373.1K$4M+1.89%
Q4 202273.3K$3,375+1.73%
Q3 202273.8K$4M+2.05%
Q2 202271.4K$3M+1.72%
Q1 202271.5K$3M+1.55%
Q4 202171.8K$4M+1.49%
Q3 202171.2K$4M+1.71%
Q2 202190.1K$6M+1.88%
Q1 202193.1K$5M+1.51%
Q4 202094.1K$4M+1.45%
Q3 202095.0K$3M+1.48%
Q2 2020104.2K$3M+1.26%
Q1 2020100.9K$3M+1.22%
Q4 201969.1K$2M+1.02%
Q3 201955.9K$2M+0.82%
Q2 201943.8K$1M+0.67%
Q1 201943.6K$1M+0.79%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Bridge City Capital, LLC’s full portfolio or all institutional holders of LMAT.